Want to see SE:BINV full AI Analyst Report?
BioInvent International AB (BINV) Ratios
BioInvent International AB Ratios
SE:BINV's free cash flow for Q3 2026 was $-113.70M. For the 2026 fiscal year, SE:BINV's free cash flow was decreased by $-153.00K and operating cash flow was $-113.55M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.67 | 9.91 | 14.93 | 12.41 | 18.98 |
| Quick Ratio | 5.56 | 9.79 | 14.77 | 12.28 | 18.70 |
| Cash Ratio | 3.17 | 4.57 | 3.42 | 5.90 | 15.49 |
| Solvency Ratio | -2.76 | -3.97 | -3.47 | -0.18 | -3.29 |
| Operating Cash Flow Ratio | -2.20 | -4.00 | -4.50 | -0.47 | -4.18 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 524.11M | $ 839.79M | $ 1.04B | $ 977.97M | $ 1.04B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 1.12 | 1.07 | 1.07 | 1.06 |
| Debt Service Coverage Ratio | 0.00 | -737.87 | -490.46 | -28.79 | -510.32 |
| Interest Coverage Ratio | 0.00 | -848.75 | -579.85 | -78.34 | -538.39 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.15 | 0.27 | 0.36 | 0.45 | 0.53 |
| Net Debt to EBITDA | 1.05 | 1.02 | 0.76 | 17.99 | 3.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -155.14% | -959.33% | -461.04% | -12.83% | -1433.80% |
| EBITDA Margin | -146.37% | -916.14% | -437.59% | -8.32% | -1358.42% |
| Operating Profit Margin | -155.14% | -1054.15% | -517.68% | -15.61% | -1435.98% |
| Pretax Profit Margin | -146.79% | -960.57% | -461.93% | -13.03% | -1436.46% |
| Net Profit Margin | -146.96% | -960.87% | -462.22% | -10.45% | -1439.13% |
| Continuous Operations Profit Margin | -146.96% | -960.87% | -462.22% | -13.03% | -1436.46% |
| Net Income Per EBT | 100.12% | 100.03% | 100.06% | 80.19% | 100.19% |
| EBT Per EBIT | 94.61% | 91.12% | 89.23% | 83.47% | 100.03% |
| Return on Assets (ROA) | -49.59% | -43.40% | -23.59% | -1.99% | -19.27% |
| Return on Equity (ROE) | -59.69% | -48.47% | -25.22% | -2.12% | -20.41% |
| Return on Capital Employed (ROCE) | -62.89% | -52.69% | -27.94% | -3.13% | -20.05% |
| Return on Invested Capital (ROIC) | -62.07% | -52.15% | -27.75% | -2.50% | -19.95% |
| Return on Tangible Assets | -49.59% | -43.40% | -23.59% | -1.99% | -19.27% |
| Earnings Yield | -17.21% | -16.95% | -28.14% | -1.73% | -11.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.94 | 1.43 | 5.99 | 8.92 | 2.06 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 6.76 | 0.98 | 1.36 | 6.27 | 0.39 |
| Asset Turnover | 0.34 | 0.05 | 0.05 | 0.19 | 0.01 |
| Working Capital Turnover Ratio | 0.33 | 0.05 | 0.07 | 0.32 | 0.02 |
| Cash Conversion Cycle | 52.62 | 255.23 | 60.93 | 40.94 | 176.89 |
| Days of Sales Outstanding | 52.62 | 255.23 | 60.93 | 40.94 | 176.89 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 52.62 | 255.23 | 60.93 | 40.94 | 176.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.77 | -5.78 | -5.19 | -0.67 | -4.54 |
| Free Cash Flow Per Share | -3.88 | -5.93 | -5.40 | -0.87 | -4.78 |
| Dividend Paid and CapEx Coverage Ratio | -34.13 | -37.92 | -25.68 | -3.33 | -18.54 |
| Capital Expenditure Coverage Ratio | -34.13 | -37.92 | -25.68 | -3.33 | -18.54 |
| Operating Cash Flow Coverage Ratio | -25.58 | -21.85 | -14.70 | -1.53 | -8.67 |
| Operating Cash Flow to Sales Ratio | -1.09 | -8.51 | -4.78 | -0.13 | -12.68 |
| Free Cash Flow Yield | -13.19% | -15.41% | -30.24% | -2.72% | -10.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.81 | -5.90 | -3.55 | -57.85 | -8.97 |
| Price-to-Sales (P/S) Ratio | 8.54 | 56.69 | 16.43 | 6.05 | 129.09 |
| Price-to-Book (P/B) Ratio | 3.47 | 2.86 | 0.90 | 1.23 | 1.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.58 | -6.49 | -3.31 | -36.78 | -9.66 |
| Price-to-Operating Cash Flow Ratio | -7.81 | -6.66 | -3.44 | -47.83 | -10.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.26 | -0.20 | -0.00 | 0.65 | -0.10 |
| Enterprise Value Multiple | -4.79 | -5.17 | -3.00 | -54.69 | -6.15 |
| Enterprise Value | 1.59B | 2.12B | 937.53M | 1.48B | 1.62B |
| EV to EBITDA | -4.79 | -5.17 | -3.00 | -54.69 | -6.15 |
| EV to Sales | 7.01 | 47.35 | 13.12 | 4.55 | 83.57 |
| EV to Free Cash Flow | -6.23 | -5.42 | -2.64 | -27.68 | -6.25 |
| EV to Operating Cash Flow | -6.41 | -5.56 | -2.74 | -35.99 | -6.59 |
| Tangible Book Value Per Share | 8.48 | 13.46 | 19.91 | 26.11 | 25.24 |
| Shareholders’ Equity Per Share | 8.48 | 13.46 | 19.91 | 26.11 | 25.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.20 | -0.00 |
| Revenue Per Share | 3.44 | 0.68 | 1.09 | 5.30 | 0.36 |
| Net Income Per Share | -5.06 | -6.53 | -5.02 | -0.55 | -5.15 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.80 | 1.00 |
| Interest Burden | 0.95 | 1.00 | 1.00 | 1.02 | 1.00 |
| Research & Development to Revenue | 2.23 | 10.24 | 5.46 | 1.00 | 13.33 |
| SG&A to Revenue | 0.33 | 1.30 | 0.72 | 0.16 | 2.03 |
| Stock-Based Compensation to Revenue | 0.02 | 0.12 | 0.04 | 0.01 | 0.06 |
| Income Quality | 0.74 | 0.81 | 1.03 | 0.81 | 0.88 |
Currency in SEK